Identification of Hydromorph Contin-Controlled Release Cap - 30Mg:
No description |
Search images on Google Product Monograph
Active Ingredients:
- hydromorphone hydrochloride, 30 MG
DIN: 02125390
Dosage Form(s): CAPSULE (SUSTAINED-RELEASE)
Route(s) of Administration: ORAL
Schedule: Narcotic (CDSA I)
Company: PURDUE PHARMA – official site
ATC:
- N02 - ANALGESICS (ATC, WHO, Wiki)
- N02A - OPIOIDS (ATC, WHO)
- N02AA - Natural opium alkaloids (ATC, WHO)
- N02AA03 - HYDROMORPHONE (WHO)
Reference brand drug: Dilaudid, Jurnista
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 50
Pharmaceutical standard: MFR
External Links for Hydromorph Contin-Controlled Release Cap - 30Mg:
Search on Google
- Hydromorph Contin-Controlled Release Cap - 30Mg side effects
- Hydromorph Contin-Controlled Release Cap - 30Mg dosage
- hydromorphone hydrochloride side effects
- hydromorphone hydrochloride dosage
Purdue Pharma
Go to Purdue website to see drug product details. Sometimes you can find hydromorph contin-controlled release cap - 30mg photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.